Alpine Immune Sciences, Inc. (NASDAQ: ALPN), is a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- orbest-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development.

Biotechnology

Health Care

Alpine Immune Sciences

Stephanie Wisdo

Stanford Peng

Rupert Davies

Andrew Sandler

Kelly Mumma, SPHR (she / her)

Devon Campbell

Thaedra Thullbery, CPA

Remy Durand

Gary Albert

The Research and Clinical Science team at Alpine Immune Sciences develops and advances innovative immunotherapies for autoimmune and inflammatory diseases. They conduct cutting-edge research, design clinical trials, analyze biomarker data, and optimize protein engineering technologies to support Alpine's diverse pipeline of clinical and preclinical candidates. This team collaborates closely with global biopharmaceutical partners to bring groundbreaking treatments from the lab to patients.

Research and Clinical Science

Clinical and Medical Operations

Leadership Team

Research and Clinical Science

About

Team members

Other teams at Alpine Immune Sciences

Clinical and Medical Operations

Leadership Team